Drug Enforcement D-0225-2024

Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.

Status

Ongoing

Classification

Class I

Report Date

December 6, 2023

Termination Date

—

Product Information

Product description
Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598
Product quantity
—
Reason for recall
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Recall initiation reason
—
Initial firm notification
Telephone
Distribution pattern
USA Nationwide

Location & Firm

Recalling firm
Botanical Be
Address
360 Jardin Bello

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0225-2024
Event ID
93257
Recall initiation date
October 20, 2023
Center classification date
January 12, 2024
Code info
All lots, exp 10/20/2024
More code info
—